PreveCeutical Medical Inc. (PRVCF)
- Newsfile
PreveCeutical Engages Outside The Box Capital Inc. to Provide Marketing Services
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that it has entered into a Marketing Service Agreement dated effective September 1, 2024 (the "Agreement") with Outside the Box Capital Ltd. ("OTB"), whereby OTB will provide the Company with certain marketing services (the "Services").As consideration for the Services, the Company will pay OTB a cash fee in the aggrega
- Newsfile
Preveceutical Announces Revocation of Management Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that, further to the Company's news release dated June 28, 2024, the Company has completed the filings of its interim financial statements, accompanying management's discussion and analysis and related CEO and CFO certificates for the period ended March 31, 2024 (the "Q1 Filings"). Accordingly, the management cea
- Newsfile
PreveCeutical Provides Update on Management Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - June 28, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that today it has filed its audited annual financial statements and accompanying management's discussion and analysis, with related CEO and CFO certificates, for the financial year ended December 31, 2023 (collectively, the "Annual Filings"). The Annual Filings are available on SEDAR+ as well as the CSE website.
